These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16603441)

  • 1. Reduced incidence of slowly progressive Heymann nephritis in rats immunized with a modified vaccination technique.
    Barabas AZ; Cole CD; Barabas AD; Barabas AN; Lafreniere R
    Clin Dev Immunol; 2006 Mar; 13(1):17-24. PubMed ID: 16603441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rat kidney fraction 3 (rKF3) antigen and specific IgM antibody against rKF3 on the progression of slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Barabas AN; Lafreniere R
    Pathol Int; 2006 Sep; 56(9):516-29. PubMed ID: 16930332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of a pathogenic autoantibody response by IgM autoantibodies directed against the nephritogenic antigen in slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Pathol Int; 2006 Apr; 56(4):181-90. PubMed ID: 16634963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of Heymann nephritis by a chemically modified renal antigen.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2004 Oct; 85(5):277-85. PubMed ID: 15379960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2004 Dec; 85(6):321-34. PubMed ID: 15566429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of a new model of slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2003 Dec; 84(6):245-58. PubMed ID: 14748744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Lafreniere R; Weir DM
    Autoimmunity; 2012 Nov; 45(7):495-509. PubMed ID: 22816962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease.
    Barabas AZ; Lafreniere R
    Autoimmun Rev; 2005 Nov; 4(8):565-70. PubMed ID: 16214097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of heterologous IgG antibody against Heymann nephritis antigen by injections of immune complexes.
    Barabas AZ; Cole CD; Sensen M; Lafreniere R
    Int J Exp Pathol; 2012 Feb; 93(1):11-7. PubMed ID: 22103575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive Heymann nephritis in pre- and post-natal rats.
    Challice J; Barabas AZ; Cornish J; Bruce JW; Lannigan R
    Br J Exp Pathol; 1986 Dec; 67(6):915-24. PubMed ID: 3542009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subsets in Heymann nephritis.
    Cheng IK; Dorsch SE; Hall BM
    Lab Invest; 1984 Sep; 51(3):286-91. PubMed ID: 6381880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of pre-injection of rat kidney F3 antigen on the development of passive Heymann nephritis.
    Cornish J; Barabas AZ; Lannigan R
    Br J Exp Pathol; 1983 Feb; 64(1):53-6. PubMed ID: 6340713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies.
    Wu H; Walters G; Knight JF; Alexander SI
    J Immunol; 2003 Nov; 171(9):4824-9. PubMed ID: 14568961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of the pathogenic pronase-digested renal proximal tubular antigen and antibody in rat active Heymann nephritis.
    Maezawa A; Tsukada Y; Yano S; Naruse T
    Nephron; 1995; 71(4):448-53. PubMed ID: 8587626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis.
    Miettinen A; Törnroth T; Ekblom P; Virtanen I; Linder E
    Lab Invest; 1984 Apr; 50(4):435-46. PubMed ID: 6708453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.
    Lotan D; Kaplan BS; Fong JS; Goodyer PR; de Chadarevian JP
    Kidney Int; 1984 May; 25(5):778-88. PubMed ID: 6471664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of Heymann nephritis with a gp330/megalin fusion protein.
    Raychowdhury R; Zheng G; Brown D; McCluskey RT
    Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of renal transplantation in rats on glomerular and tubular immune complexes.
    Hoyer JR; Seiler MW
    Am J Kidney Dis; 1986 Jan; 7(1):69-75. PubMed ID: 2934976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.